{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:17:09Z","timestamp":1778249829476,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-026-04376-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:29:02Z","timestamp":1771950542000},"page":"915-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"49","author":[{"given":"Cynthia","family":"De La Garza-Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Gil-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beau B.","family":"Toskich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"19","key":"4376_CR1","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3748\/wjg.v19.i19.2935","volume":"19","author":"I Rodr\u00edguez-Lago","year":"2013","unstructured":"Rodr\u00edguez-Lago I, Carretero C, Herr\u00e1iz M, et al. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors. World J Gastroenterol. 2013;19(19):2935\u201340.","journal-title":"World J Gastroenterol"},{"issue":"13","key":"4376_CR2","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1007\/s00259-015-3122-6","volume":"42","author":"VL Gates","year":"2015","unstructured":"Gates VL, Hickey R, Marshall K, et al. Gastric injury from (90)Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction? Eur J Nucl Med Mol Imaging. 2015;42(13):2038\u201344.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"4376_CR3","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s10620-010-1156-y","volume":"55","author":"S Naymagon","year":"2010","unstructured":"Naymagon S, Warner RR, Patel K, et al. Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature. Dig Dis Sci. 2010;55(9):2450\u20138.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4376_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.gie.2009.03.015","volume":"70","author":"A Konda","year":"2009","unstructured":"Konda A, Savin MA, Cappell MS, Duffy MC. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity. Gastrointest Endosc. 2009;70(3):561\u20137.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"4376_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hep.24451","volume":"54","author":"B Sangro","year":"2011","unstructured":"Sangro B, Carpanese L, Cianni R, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology. 2011;54(3):868\u201378.","journal-title":"Hepatology"},{"issue":"9","key":"4376_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","volume":"20","author":"A Riaz","year":"2009","unstructured":"Riaz A, Lewandowski RJ, Kulik LM, et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009;20(9):1121\u201331.","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"4376_CR7","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jvir.2021.07.016","volume":"32","author":"JW Jung","year":"2021","unstructured":"Jung JW, Foster HS, Tabori NE, Sivananthan G. Yttrium-90 radioembolization complicated by colitis. J Vasc Interv Radiol. 2021;32(12):1698\u20139.","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"4376_CR8","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jvir.2021.09.001","volume":"32","author":"W Zhou","year":"2021","unstructured":"Zhou W, Sze DY. Gastric outlet obstruction following radioembolization: extrahepatic complication from proximity to a superficial hepatic tumor treated with an ablative dose. J Vasc Interv Radiol. 2021;32(12):1699\u2013701.","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"4376_CR9","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1007\/s00259-022-05776-y","volume":"49","author":"SA Montazeri","year":"2022","unstructured":"Montazeri SA, la De Garza-Ramos C, Lewis AR, et al. Hepatocellular carcinoma radiation segmentectomy treatment intensification prior to liver transplantation increases rates of complete pathologic necrosis: an explant analysis of 75 tumors. Eur J Nucl Med Mol Imaging. 2022;49(11):3892\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"4376_CR10","first-page":"1520","volume":"21","author":"LG Melstrom","year":"2019","unstructured":"Melstrom LG, Eng OS, Raoof M, et al. Is hepatectomy safe following Yttrium-90 therapy? A Multi-Institu Int Exp HPB. 2019;21(11):1520\u20136.","journal-title":"A Multi-Institu Int Exp HPB"},{"key":"4376_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2147\/JHC.S319215","volume":"8","author":"C De la Garza-Ramos","year":"2021","unstructured":"De la Garza-Ramos C, Overfield CJ, Montazeri SA, et al. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated. J Hepatocell Carcinoma. 2021;8:861\u201370.","journal-title":"J Hepatocell Carcinoma"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-026-04376-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-026-04376-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:56:29Z","timestamp":1778248589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-026-04376-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":11,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4376"],"URL":"https:\/\/doi.org\/10.1007\/s00270-026-04376-9","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.B.T. is a consultant for ABK, AstraZeneca, BD, Boston Scientific, Delcath, Galvanize Therapeutics, Genentech, Eisai, Replimmune, Immunocore,\u00a0Sirtex Medical, Terumo Medical, Turnstone Biologics, Johnson and Johnson, HistoSonics, and Vivos.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}